Aegerion Pharmaceuticals, Inc.Enters Oversold Territory - Tale of the Tape

Comment

Shutterstock photo

Aegerion Pharmaceuticals, Inc. 's ( AEGR ) share price has entered into oversold territory with a stochastic value of 7.5739. The Zacks Consensus Estimate on the company's loss for December 2012 decreased by 21 cents over the past two months to $2.29 per share. Aegerion Pharmaceuticals, Inc. is a Zacks #2 Rank (" Buy") company.

 


 
AEGERION PHARMA (AEGR): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: Investing , Investing Ideas , Stocks


More from Zacks.com

Subscribe






Zacks.com
Contributor:

Zacks.com

Equity Research
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com